Concepedia
Statistics
Publications
14
Citations
726
H-Index
13
Active since
1996
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
University of Cambridge
University of Basel
Novartis (United States)
Daniel K. Baeschlin is an author at Novartis (Switzerland) specializing in pharmacology, drug discovery, and medicinal chemistry.
Publications per year
1996–2023
Concise Asymmetric Syntheses of Radicicol and Monocillin I
R. M. Garbaccio, Shawn J. Stachel, Daniel K. Baeschlin et al. · Journal of the American Chemical Society · 2001 · 144 citations
Pharmacy, Medicinal Chemistry, Pharmacology +16
Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor ofTrypanosoma brucei
Daniel K. Baeschlin, André Chaperon, Virginie Charbonneau et al. · Angewandte Chemie International Edition · 1998 · 100 citations
Life Sciences, Biochemistry, Molecular Biology +17
1,2-Diacetals in Synthesis: Total Synthesis of a Glycosylphosphatidylinositol Anchor ofTrypanosoma brucei
Daniel K. Baeschlin, André Chaperon, Luke G. Green et al. · Chemistry - A European Journal · 2000 · 95 citations
Life Sciences, Biochemistry, Carbohydrate Chemistry +12
Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes
Jon M. Sutton, David E. Clark, Stephen J. Dunsdon et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 73 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
Rapid assembly of oligosaccharides: 1,2-diacetal-mediated reactivity tuning in the coupling of glycosyl fluorides
Daniel K. Baeschlin, Luke G. Green, Michael G. Hahn et al. · Tetrahedron Asymmetry · 2000 · 63 citations
Life Sciences, Biochemistry, Chemistry +10
1–5 of 14